Latest California Healthline Stories
Even under a decent plan, you’ll have to dig deep in your pocket for crowns, bridges and implants. The mouth isn’t covered by insurance the same way as the rest of the body, and this division has deep roots in history and tradition.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
As many as 16 million people in the United States have undiagnosed or uncorrected vision problems that could be fixed with eyeglasses, contact lenses or surgery.
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
A proposed change in immigration policy from the Trump administration could make it more difficult for immigrants to obtain a green card if family members use Medicaid or other government benefits for medical care. The “chilling effects” of the draft proposal already are being felt in California community health centers, one official said.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children’s Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.
All private health plans, Medicare, state Medicaid programs and the VA now cover some e-visits — albeit with restrictions.
President Donald Trump is recommending that Congress approve his plan to take back about $7 billion in funding for the Children’s Health Insurance Plan. Experts are divided about whether it would have any effect.
The Centers for Medicare & Medicaid Services rejects a plan by Kansas to cap benefits at three years.
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.